Appointments

866.320.4573

Request an Appointment

Questions

800.223.2273

Contact us with Questions

Expand Content

Arthur McCullough, MD

216.444.7000

Arthur McCullough, MD
Department: Gastroenterology and Hepatology
Location: Cleveland Clinic Main Campus
Mail Code A30
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.7000
DeskDesk:216.444.6521
WorkFax:216.445.3889
Arthur McCullough, MD
Department: Pathobiology
Location: Cleveland Clinic Main Campus
Mail Code A30
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.7000
DeskDesk:216.444.6521
WorkFax:216.445.3889
Arthur McCullough, MD
Department: Transplantation Center
Location: Cleveland Clinic Main Campus
Mail Code A30
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.7000
DeskDesk:216.444.6521
WorkFax:216.445.3889
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Arthur McCullough, MD, is a staff physician in the Department of Gastroenterology and Hepatology and a Staff Physician in the Department of Pathobiology and Transplantation Center at Cleveland Clinic. He was appointed in 2006.
 
He attended medical school at SUNY Health Science Center at University Hospital of Syracuse, N.Y. He completed his internship and residency at Cleveland Clinic and a fellowship at Mayo Clinic in Rochester, Minn. 

Professional Highlights

  • President of the American Association for the Study of Liver Diseases

Education & Fellowships

Fellowship - Mayo Clinic
NIH Fellow in Gastroenterology
Rochester, MN USA
1980
Residency - Cleveland Clinic
Internal Medicine
Cleveland, OH USA
1977
Internship - Cleveland Clinic
Internal Medicine
Cleveland, OH USA
1975
Medical School - SUNY Upstate Medical University
Syracuse, NY USA
1974
Undergraduate - Fordham University
Bronx, NY USA
1970

Certifications

  • Internal Medicine
  • Internal Medicine- Gastroenterology

Specialty Interests

biliary disorders, biliary tract disease, clinical epidemiology, Diagnostic and therapeutic EGD (upper endoscopy) and colonoscopy, diagnostic and therapeutic endoscopy, diagnostic/therapeutic endoscopy, drug induced liver disease, Education of Fellows/Residents, end stage liver disease, Endoscopy, Eval and management of Hepatobiliary Malignancies, general hepatology, insulin resistance, liver, liver and biliary tract disease, Liver Disease, Liver Transplantation, liver-biliary tract disease, Medical School Education, Metabolic Syndrome, non alcoholic fatty liver disease, skeletal muscle loss in liver disease

Awards & Honors

  • Best Doctor's in America: "Midwest Region" annually from 1996-2008
  • Chair of the NIH-funded Clinical Research Network on Fatty Liver Disease (federal funding)
  • NIH Grant on Omega 3 Fatty Acids in Diabetes (federal funding)
  • New Novel Agents for Hepatitis C Patients who failed to respond to previous therapy (non-federal funding)

Innovations & Patents

Helped develop a non-invasive test for liver disease without needing a liver biopsy

Memberships

  • American Association for the Study of Liver Disease
  • American Gastroenterology Association
  • American College of Gastroenterology
  • American College of Physicians
  • European Association for Liver Disease

Treatment & Services

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 12/17/2013, Dr. McCullough has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English